MedPath

aloxone As an Adjuvant To Fenanyl-Bupivacaine in Thoracic Paravertebral Block Analgesia

Not Applicable
Conditions
Cancer
Surgery
Thoracic Paravertebral Block Analgesia after modified radical mastectomy
Registration Number
PACTR201709002599279
Lead Sponsor
tanta university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
135
Inclusion Criteria

135 patients, ASA I &II, age 40-60 years, from both sex scheduled to undergoing unilateral modified radical mastectomy

Exclusion Criteria

¿Patients with known allergy to amide type local anesthetics
¿Patients receiving non-steroidal anti-inflammatory drugs
¿Schizophrenia or other psychotic disorder or cognitive impairment
¿ History of drug dependency or substance addiction
¿BMI <18.5 or >30 kg m2
¿coagulation disorders
¿local skin infection at the side of injection, spinal metastasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
postoperative pain
Secondary Outcome Measures
NameTimeMethod
Depth of anaesthesia
© Copyright 2025. All Rights Reserved by MedPath